AG
CDNA icon

Algert Global’s CareDx CDNA Stock Holding History

Algert Global’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,510
Closed -$773K – 1271
2026
Q1 		$773K Sell
44,510
-25,640
-37% -$485K 0.01% 911
2025
Q4 		$1.32M Buy
70,150
+27,840
+66% +$466K 0.02% 795
2025
Q3 		$615K Buy
42,310
+20,920
+98% +$298K 0.01% 902
2025
Q2 		$418K Hold
21,390
– – 0.01% 970
2025
Q1 		$380K Sell
21,390
-14,650
-41% -$316K 0.01% 964
2024
Q4 		$772K Buy
36,040
+7,460
+26% +$181K 0.02% 838
2024
Q3 		$892K Buy
+28,580
New +$711K 0.02% 769
2023
Q4 		– Sell
-125,210
Closed -$876K – 1143
2023
Q3 		$876K Sell
125,210
-6,970
-5% -$64.4K 0.04% 592
2023
Q2 		$1.12M Buy
132,180
+102,220
+341% +$852K 0.05% 616
2023
Q1 		$274K Sell
29,960
-16,765
-36% -$214K 0.01% 964
2022
Q4 		$533K Buy
46,725
+790
+2% +$11.7K 0.03% 786
2022
Q3 		$782K Buy
45,935
+27,398
+148% +$588K 0.05% 643
2022
Q2 		$398K Sell
18,537
-16,872
-48% -$468K 0.03% 834
2022
Q1 		$1.31M Buy
35,409
+14,912
+73% +$581K 0.09% 399
2021
Q4 		$932K Buy
20,497
+5,850
+40% +$305K 0.12% 294
2021
Q3 		$928K Buy
+14,647
New +$1.12M 0.12% 259

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's CDNA Position: Q2 2026 in Review

Algert Global sold out of CareDx (CDNA) in Q2 2026, closing a stake of 44,510 shares — an estimated $773K sold.

Algert Global first reported a position in CDNA in Q3 2021 and held it in 16 quarters. The position peaked at $1.32M in Q4 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Algert Global reported no remaining CareDx position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 44,510 CareDx shares in Q2 2026, an estimated $773K.
  • Algert Global first reported a position in CareDx in Q3 2021 and held it in 16 quarters.
  • Algert Global's CareDx position peaked at $1.32M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.